Cargando…
Real world data from a multi-centre study on the effects of cilostazol on pain symptoms and walking distance in patients with peripheral arterial disease
OBJECTIVE: to assess the effects of cilostazol on pain-free walking distance in PAD patients with IC at 3 and 6 months in a real world, prospective, observational study. We included 1015 PAD patients presenting with IC (71.3% men, 93.5% white, mean age 69.2 ± 8.7 years). Patients were followed up fo...
Autores principales: | Katsiki, Niki, Tentolouris, Nikolaos, Marakomichelakis, Georgios, Richter, Dimitrios, Giannoukas, Athanasios, Koufaki, Panagiota, Papanas, Nikolaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764459/ https://www.ncbi.nlm.nih.gov/pubmed/36536424 http://dx.doi.org/10.1186/s13104-022-06264-0 |
Ejemplares similares
-
Association of serum levels of osteopontin and osteoprotegerin with adverse outcomes after endovascular revascularisation in peripheral artery disease
por: Kadoglou, Nikolaos P. E., et al.
Publicado: (2022) -
Dryness of Foot Skin Assessed by the Visual Indicator Test and Risk of Diabetic Foot Ulceration: A Prospective Observational Study
por: Panagoulias, Georgios S., et al.
Publicado: (2020) -
Metabolic Syndrome and Abnormal Peri-Organ or Intra-Organ Fat (APIFat) Deposition in Chronic Obstructive Pulmonary Disease: An Overview
por: Katsiki, Niki, et al.
Publicado: (2020) -
Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel‐Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events
por: Kalantzi, Kallirroi, et al.
Publicado: (2020) -
Management of peripheral arterial disease in the elderly: focus on cilostazol
por: Falconer, Travis M, et al.
Publicado: (2008)